Feng Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Feng Zhu has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Lin Xu
School of Public Health, Sun Yat-sen University, Guangzhou, China
12 shared publications - Wei Sen Zhang
Guangzhou Twelfth People’s Hospital, Guangzhou, China
10 shared publications - Kar Keung Cheng
Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
9 shared publications Qiong-Qiong Zhong
Departments of Public Health and Preventive Medicine, Jinan University, Guangzhou, China
8 shared publications- Ya Li Jin
Guangzhou Twelfth People’s Hospital, Guangzhou, China
8 shared publications - Jing Pan
The Affiliated Guangzhou Twelfth People's Hospital, Guangzhou Medical University, Guangzhou, China.
7 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1858148
Low-dose esketamine for postoperative pain, sleep, and hemodynamic stability in functional endoscopic sinus surgery: a retrospective cohort study
Objective: To evaluate the efficacy and safety of low-dose esketamine (0.2 mg/kg or 0.3 mg/kg) in improving postoperative pain, sleep quality, hemodynamic stability, and emotional status in functional endoscopic sinus surgery (FESS) patients. Methods: This retrospective cohort study analysed 135 chronic rhinosinusitis patients (January 2021–December 2023) divided into control (normal saline, n = 45), 0.2 mg/kg esketamine ( n = 45), and 0.3 mg/kg esketamine ( n = 45) groups. Propensity score matching (PSM)-balanced baselines. Primary outcome: 24-hour post-operative VAS pain score. Secondary outcomes included sleep/emotion/hemodynamic indices and adverse events. Python-based statistical analyses were performed. Results: After PSM, 40 patients/group were analysed. The 0.3 mg/kg (5.82 ± 1.89) and 0.2 mg/kg (6.53 ± 1.59) groups had significantly lower 24-hour VAS scores than the control group did (7.16 ± 0.93, P < 0.001), with the 0.3 mg/kg group being superior ( P = 0.032). The eyesketamine group had better sleep quality (PSQI: 3.53 ± 0.69–6.31 ± 0.51 vs. 9.07 ± 1.12; P < 0.001), reduced anxiety/depression (HAM-A/HAM-D), improved resilience (CD-RISC), and less vasoactive drug use ( P < 0.001). Adverse events were lower, with no increased neuropsychiatric reactions. Conclusion: The use of low-dose esketamine (particularly 0.3 mg/kg) in FESS patients is associated with clinically meaningful improvements in pain control, sleep quality, emotional well-being, and hemodynamic parameters, alongside a favorable safety profile with no increase in neuropsychiatric adverse events. These findings support its consideration as a viable non-opioid analgesic adjunct in this surgical setting.
- 11 August 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1858148
Open AccessLow-dose esketamine for postoperative pain, sleep, and hemodynamic stability in functional endoscopic sinus surgery: a retrospective cohort study
Objective: To evaluate the efficacy and safety of low-dose esketamine (0.2 mg/kg or 0.3 mg/kg) in improving postoperative pain, sleep quality, hemodynamic stability, and emotional status in functional endoscopic sinus surgery (FESS) patients. Methods: This retrospective cohort study analysed 135 chronic rhinosinusitis patients (January 2021–December 2023) divided into control (normal saline, n = 45), 0.2 mg/kg esketamine ( n = 45), and 0.3 mg/kg esketamine ( n = 45) groups. Propensity score matching (PSM)-balanced baselines. Primary outcome: 24-hour post-operative VAS pain score. Secondary outcomes included sleep/emotion/hemodynamic indices and adverse events. Python-based statistical analyses were performed. Results: After PSM, 40 patients/group were analysed. The 0.3 mg/kg (5.82 ± 1.89) and 0.2 mg/kg (6.53 ± 1.59) groups had significantly lower 24-hour VAS scores than the control group did (7.16 ± 0.93, P < 0.001), with the 0.3 mg/kg group being superior ( P = 0.032). The eyesketamine group had better sleep quality (PSQI: 3.53 ± 0.69–6.31 ± 0.51 vs. 9.07 ± 1.12; P < 0.001), reduced anxiety/depression (HAM-A/HAM-D), improved resilience (CD-RISC), and less vasoactive drug use ( P < 0.001). Adverse events were lower, with no increased neuropsychiatric reactions. Conclusion: The use of low-dose esketamine (particularly 0.3 mg/kg) in FESS patients is associated with clinically meaningful improvements in pain control, sleep quality, emotional well-being, and hemodynamic parameters, alongside a favorable safety profile with no increase in neuropsychiatric adverse events. These findings support its consideration as a viable non-opioid analgesic adjunct in this surgical setting.
- Open Access
- 15 July 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Associations of sleep duration, physical activity, and longitudinal changes with the risk of fatal stroke occurrence in middle-aged to older individuals
Sleep and physical activity (PA) are associated with the risk of stroke, but the relationships between longitudinal changes in sleep and PA habits and between their combination index and fatal stroke are unclear. In this prospective cohort study on the risks of stroke and sleep and physical activity (PA), 26,672 participants with 951 stroke deaths in the Guangzhou Biobank Cohort Study (GBCS) and 7218 participants with 49 stroke deaths in the National Health and Nutrition Examination Survey (NHANES) were enrolled after mean follow-up times of 15.4 (SD = 3.57) and 6.71 (SD = 3.43) years, respectively. Compared with stable participants, GBCS participants with sleep durations ≤ 5 and ≥ 9 h were at greater risk for fatal all-stroke (aHR = 1.35, 95% CI: 1.10-1.66, P = 0.004; aHR = 1.47, 95% CI: 1.16-1.87, P = 0.001) and fatal ischemic stroke (aHR = 1.52, 95% CI: 1.14-2.03, P = 0.004; aHR = 1.63, 95% CI: 1.18-2.27, P = 0.003); longitudinally increased sleep duration was associated with greater risks for fatal all-stroke (aHR = 1.34, 95% CI: 1.04-1.72, P = 0.02) and fatal ischemic stroke (aHR = 1.51, 95% CI: 1.08-2.12, P = 0.02), and greater risks for fatal ischemic stroke were presented in moderate-inactive PA (aHR = 3.24, 95% CI: 1.49-7.05, P = 0.003). The NHANES substandard PA had a greater risk for fatal all-stroke (aHR = 2.86, 95% CI: 1.54-5.30, P < 0.001) than did standard PA; a greater risk of fatal all-stroke was associated with short sleep + substandard PA (aHR = 7.11, 95% CI: 2.46-20.54, P < 0.001) and normal sleep + substandard PA (aHR = 2.46, 95% CI: 1.16-5.24, P = 0.02) than with normal sleep + standard PA. Abnormal sleep and longitudinal changes in sleep and substandard PA are associated with an increased risk of fatal stroke occurrence; these findings may be potential indicators of future fatal stroke occurrence in relatively healthy middle-aged to older individuals.
- 15 July 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessAssociations of sleep duration, physical activity, and longitudinal changes with the risk of fatal stroke occurrence in middle-aged to older individuals
Sleep and physical activity (PA) are associated with the risk of stroke, but the relationships between longitudinal changes in sleep and PA habits and between their combination index and fatal stroke are unclear. In this prospective cohort study on the risks of stroke and sleep and physical activity (PA), 26,672 participants with 951 stroke deaths in the Guangzhou Biobank Cohort Study (GBCS) and 7218 participants with 49 stroke deaths in the National Health and Nutrition Examination Survey (NHANES) were enrolled after mean follow-up times of 15.4 (SD = 3.57) and 6.71 (SD = 3.43) years, respectively. Compared with stable participants, GBCS participants with sleep durations ≤ 5 and ≥ 9 h were at greater risk for fatal all-stroke (aHR = 1.35, 95% CI: 1.10-1.66, P = 0.004; aHR = 1.47, 95% CI: 1.16-1.87, P = 0.001) and fatal ischemic stroke (aHR = 1.52, 95% CI: 1.14-2.03, P = 0.004; aHR = 1.63, 95% CI: 1.18-2.27, P = 0.003); longitudinally increased sleep duration was associated with greater risks for fatal all-stroke (aHR = 1.34, 95% CI: 1.04-1.72, P = 0.02) and fatal ischemic stroke (aHR = 1.51, 95% CI: 1.08-2.12, P = 0.02), and greater risks for fatal ischemic stroke were presented in moderate-inactive PA (aHR = 3.24, 95% CI: 1.49-7.05, P = 0.003). The NHANES substandard PA had a greater risk for fatal all-stroke (aHR = 2.86, 95% CI: 1.54-5.30, P < 0.001) than did standard PA; a greater risk of fatal all-stroke was associated with short sleep + substandard PA (aHR = 7.11, 95% CI: 2.46-20.54, P < 0.001) and normal sleep + substandard PA (aHR = 2.46, 95% CI: 1.16-5.24, P = 0.02) than with normal sleep + standard PA. Abnormal sleep and longitudinal changes in sleep and substandard PA are associated with an increased risk of fatal stroke occurrence; these findings may be potential indicators of future fatal stroke occurrence in relatively healthy middle-aged to older individuals.
- Open Access
- 7 May 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1827520
Effects of noise exposure and long working hours on oxidative stress levels and high-frequency hearing threshold damage in occupational populations
Introduction: Occupational noise-induced hearing loss remains a significant public health concern in China. This study aimed to investigate the associations between combined exposure to occupational noise and long working hours with oxidative stress levels and high-frequency hearing loss (HFHL) in an occupational population. Methods: A total of 547 Chinese workers from eight manufacturing enterprises in Guangzhou who were engaged in noise-exposed occupations were recruited. Participants were divided into a noise exposure group (weekly working hours ≤40 h, n = 332) and a combined exposure group (weekly working hours >40 h, n = 215). Pure-tone audiometry was performed, and serum levels of superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GPx) were measured using colorimetric microplate assays. Nonparametric tests and binary logistic regression analyses were conducted. Results: The study included 532 males (97.3%) and 15 females (2.7%). Compared with the noise exposure group, the combined exposure group presented significantly lower SOD activity and CAT activity ( p < 0.05) and significantly higher MDA concentration ( p < 0.05). The overall prevalence of HFHL was 43.14%, with significantly higher rates in the combined exposure group ( p < 0.001). Logistic regression analysis revealed that the levels of SOD (OR = 0.869), CAT (OR = 0.963), and MDA (OR = 1.496) were significantly associated with HFHL. In forward stepwise multivariate analysis, only CAT remained an independent influencing factor (OR = 0.963, 95%CI: 0.941–0.985; p = 0.001). Conclusion: Combined exposure to noise and long working hours is associated with exacerbated oxidative stress and high-frequency hearing loss in occupational populations. CAT acts as an independent protective factor against HFHL, suggesting its potential as a biomarker for hearing damage assessment, although prospective validation is needed.
- 7 May 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1827520
Open AccessEffects of noise exposure and long working hours on oxidative stress levels and high-frequency hearing threshold damage in occupational populations
Introduction: Occupational noise-induced hearing loss remains a significant public health concern in China. This study aimed to investigate the associations between combined exposure to occupational noise and long working hours with oxidative stress levels and high-frequency hearing loss (HFHL) in an occupational population. Methods: A total of 547 Chinese workers from eight manufacturing enterprises in Guangzhou who were engaged in noise-exposed occupations were recruited. Participants were divided into a noise exposure group (weekly working hours ≤40 h, n = 332) and a combined exposure group (weekly working hours >40 h, n = 215). Pure-tone audiometry was performed, and serum levels of superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GPx) were measured using colorimetric microplate assays. Nonparametric tests and binary logistic regression analyses were conducted. Results: The study included 532 males (97.3%) and 15 females (2.7%). Compared with the noise exposure group, the combined exposure group presented significantly lower SOD activity and CAT activity ( p < 0.05) and significantly higher MDA concentration ( p < 0.05). The overall prevalence of HFHL was 43.14%, with significantly higher rates in the combined exposure group ( p < 0.001). Logistic regression analysis revealed that the levels of SOD (OR = 0.869), CAT (OR = 0.963), and MDA (OR = 1.496) were significantly associated with HFHL. In forward stepwise multivariate analysis, only CAT remained an independent influencing factor (OR = 0.963, 95%CI: 0.941–0.985; p = 0.001). Conclusion: Combined exposure to noise and long working hours is associated with exacerbated oxidative stress and high-frequency hearing loss in occupational populations. CAT acts as an independent protective factor against HFHL, suggesting its potential as a biomarker for hearing damage assessment, although prospective validation is needed.
- Open Access
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1789136
Association of FAS gene polymorphisms with the risk of noise-induced hearing loss in Chinese occupational workers
Introduction: The FAS gene, as a core regulator of the cell apoptosis pathway, has attracted considerable attention for its potential role in maintaining the homeostasis of inner ear hair cells and resisting noise-induced oxidative damage. This study aims to explore and verify the relationship between FAS gene polymorphisms and NIHL susceptibility. Subjects and methods: In this case-control study, a total of 364 noise-exposed workers were enrolled, comprising 156 NIHL cases and 208 normal-hearing controls.Genotyping of SNP loci in the FAS gene was performed using the MassArray system. Multivariate logistic regression analysis was used to evaluate the association between the identified SNPs and the susceptibility to noise-induced hearing loss (NIHL). Results: The genotype distributions in both groups were in Hardy-Weinberg equilibrium. Multivariate logistic regression analysis after adjustment for confounders showed that the T allele at the rs1468063 locus was associated with a significantly increased risk of NIHL compared to the C allele (OR = 1.79, 95% CI = 1.32–2.44, p < 0.001). In the codominant model, individuals with the CT (OR=2.14) and TT (OR = 3.86) genotypes had a higher risk compared to those with the CC genotype. Consistent with this, the recessive model (TT vs. CC + CT) also indicated that the TT genotype conferred a higher risk (OR = 2.27); for rs1800682 locus, the increased risks of NIHL were associated with G allele compared with A allele, the risk of NIHL was 2.81-fold higher in individuals with the GG genotype compared with those with the AA genotype. Conclusion: T allele at rs1468063 and G allele at rs1800682 of FAS gene were independently associated with the increased risk for NIHL, and these alleles may be potential biomarkers for early identification and risk stratification to NIHL.
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1789136
Open AccessAssociation of FAS gene polymorphisms with the risk of noise-induced hearing loss in Chinese occupational workers
Introduction: The FAS gene, as a core regulator of the cell apoptosis pathway, has attracted considerable attention for its potential role in maintaining the homeostasis of inner ear hair cells and resisting noise-induced oxidative damage. This study aims to explore and verify the relationship between FAS gene polymorphisms and NIHL susceptibility. Subjects and methods: In this case-control study, a total of 364 noise-exposed workers were enrolled, comprising 156 NIHL cases and 208 normal-hearing controls.Genotyping of SNP loci in the FAS gene was performed using the MassArray system. Multivariate logistic regression analysis was used to evaluate the association between the identified SNPs and the susceptibility to noise-induced hearing loss (NIHL). Results: The genotype distributions in both groups were in Hardy-Weinberg equilibrium. Multivariate logistic regression analysis after adjustment for confounders showed that the T allele at the rs1468063 locus was associated with a significantly increased risk of NIHL compared to the C allele (OR = 1.79, 95% CI = 1.32–2.44, p < 0.001). In the codominant model, individuals with the CT (OR=2.14) and TT (OR = 3.86) genotypes had a higher risk compared to those with the CC genotype. Consistent with this, the recessive model (TT vs. CC + CT) also indicated that the TT genotype conferred a higher risk (OR = 2.27); for rs1800682 locus, the increased risks of NIHL were associated with G allele compared with A allele, the risk of NIHL was 2.81-fold higher in individuals with the GG genotype compared with those with the AA genotype. Conclusion: T allele at rs1468063 and G allele at rs1800682 of FAS gene were independently associated with the increased risk for NIHL, and these alleles may be potential biomarkers for early identification and risk stratification to NIHL.
- Open Access
- 31 July 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (15) , e71104
External Validation of Lung Cancer Prediction Models Combining Epidemiological Predictors in Chinese Ever and Never Smokers: Guangzhou Biobank Cohort Study
Objective: This study aimed to externally validate existing lung cancer models using data from the Guangzhou Biobank Cohort Study (GBCS) and compare their predictive performance for Chinese ever and never smokers. Methods: We evaluated the discrimination and calibration of LCRAT (Lung Cancer Risk Assessment Tool), LLP version 2 (Liverpool Lung Project version 2), LLP version 3 (Liverpool Lung Project version 3), HUNT (HUNT was derived from the Nord‐Trøndelag Health Study), OWL (Optimized Early Warning Model for Lung Cancer Risk), LCRS (Lung Cancer Risk Score), PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian 2012 model), PLCOall2014 (Prostate, Lung, Colorectal, and Ovarian 2014 model), NHIS (Korean National Health Insurance Service), LLPi (Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence), Pittsburgh, and Bach models. We compared the performance of models and Chinese lung cancer screening (T/CPMA 013‐2020), US Preventive Services Task Force 2021 (USPSTF‐2021) and Nederlands–Leuvens Longkanker Screenings Onderzoek (NELSON) criteria. Results: The LLP version 2, LLP version 3, OWL, LCRS, PLCOall2014, and LLPi models showed better performance in ever smokers than in never smokers, with higher AUC (0.72–0.82 vs. 0.69–0.71) and E/O (expected to observed) ratios (0.57–0.79 vs. 0.60–0.69), while the LCRAT, HUNT, PLCOm2012, NHIS, Pittsburgh, and Bach models showed good performance in ever smokers, with AUC ranging from 0.70 to 0.79 and E/O ratios from 0.57 to 0.75. The T/CPMA 013‐2020, USPSTF‐2021, and NELSON criteria identified 56.52%–75.58% of high‐risk individuals at 5, 6, 6.6, 8.7, and 10 years, while the LCRAT, LLP version 2, LLP version 3, HUNT, OWL, LCRS, PLCOm2012, PLCOall2014, NHIS, LLPi, Pittsburgh, and Bach models identified 70.70%–89.72% of high‐risk individuals. Conclusions: Most lung cancer risk prediction models showed good performance and identified more cases than screening criteria. Replacing screening criteria with risk prediction models may increase lung cancer screening efficiency.
- 31 July 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (15) , e71104
Open AccessExternal Validation of Lung Cancer Prediction Models Combining Epidemiological Predictors in Chinese Ever and Never Smokers: Guangzhou Biobank Cohort Study
Objective: This study aimed to externally validate existing lung cancer models using data from the Guangzhou Biobank Cohort Study (GBCS) and compare their predictive performance for Chinese ever and never smokers. Methods: We evaluated the discrimination and calibration of LCRAT (Lung Cancer Risk Assessment Tool), LLP version 2 (Liverpool Lung Project version 2), LLP version 3 (Liverpool Lung Project version 3), HUNT (HUNT was derived from the Nord‐Trøndelag Health Study), OWL (Optimized Early Warning Model for Lung Cancer Risk), LCRS (Lung Cancer Risk Score), PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian 2012 model), PLCOall2014 (Prostate, Lung, Colorectal, and Ovarian 2014 model), NHIS (Korean National Health Insurance Service), LLPi (Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence), Pittsburgh, and Bach models. We compared the performance of models and Chinese lung cancer screening (T/CPMA 013‐2020), US Preventive Services Task Force 2021 (USPSTF‐2021) and Nederlands–Leuvens Longkanker Screenings Onderzoek (NELSON) criteria. Results: The LLP version 2, LLP version 3, OWL, LCRS, PLCOall2014, and LLPi models showed better performance in ever smokers than in never smokers, with higher AUC (0.72–0.82 vs. 0.69–0.71) and E/O (expected to observed) ratios (0.57–0.79 vs. 0.60–0.69), while the LCRAT, HUNT, PLCOm2012, NHIS, Pittsburgh, and Bach models showed good performance in ever smokers, with AUC ranging from 0.70 to 0.79 and E/O ratios from 0.57 to 0.75. The T/CPMA 013‐2020, USPSTF‐2021, and NELSON criteria identified 56.52%–75.58% of high‐risk individuals at 5, 6, 6.6, 8.7, and 10 years, while the LCRAT, LLP version 2, LLP version 3, HUNT, OWL, LCRS, PLCOm2012, PLCOall2014, NHIS, LLPi, Pittsburgh, and Bach models identified 70.70%–89.72% of high‐risk individuals. Conclusions: Most lung cancer risk prediction models showed good performance and identified more cases than screening criteria. Replacing screening criteria with risk prediction models may increase lung cancer screening efficiency.
- Open Access
- 28 February 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (1) , 291-303
Trajectories of lipid profile with cognitive function: 12-year follow-up of Guangzhou Biobank cohort study
Studies on the trajectories of lipid profile with cognitive decline are scarce and inconsistent. We examined this association and explored potential effect modification. Lipid profiles including high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and total cholesterol (TC) were measured at baseline, first and second follow-ups, and classified into trajectory groups. Immediate, delayed memory recall and cognitive function were assessed by the immediate (IWRT) and delayed 10-word recall test (DWRT), and mini-mental state examination (MMSE), respectively, at baseline and follow-ups, and converted into standardized scores. Linear mixed-effect model was used. Results show that elevated HDL-C was associated with increasing annual change rates in DWRT and MMSE scores (β (95% confidence intervals) = 0.005 (-0.001 to 0.011) SD/year and 0.020 (0.014 to 0.027) SD/year, respectively), while LDL-C and TC were associated with a decrease in DWRT scores (-0.005 (-0.008 to -0.001) SD/year and − 0.009 (-0.011 to -0.006) SD/year, respectively). Moderate-increasing HDL-C, high-decreasing LDL-C or moderate-decreasing TC trajectories were associated with increases in DWRT, IWRT and MMSE scores. Stronger associations were identified for HDL-C with an increase in MMSE scores within the lower family income group and for LDL-C with a decrease in IWRT scores among individuals taking lipid-lowering drug. In conclusion, HDL-C was associated with improvements, while LDL-C and TC with decline in memory and cognitive function. Increasing HDL-C and decreasing LDL-C and TC trajectories predicted better memory and cognitive performance. The observed effect modifications highlight the importance of personalized approaches in lipid management to optimize cognitive outcomes.
- 28 February 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (1) , 291-303
Open AccessTrajectories of lipid profile with cognitive function: 12-year follow-up of Guangzhou Biobank cohort study
Studies on the trajectories of lipid profile with cognitive decline are scarce and inconsistent. We examined this association and explored potential effect modification. Lipid profiles including high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and total cholesterol (TC) were measured at baseline, first and second follow-ups, and classified into trajectory groups. Immediate, delayed memory recall and cognitive function were assessed by the immediate (IWRT) and delayed 10-word recall test (DWRT), and mini-mental state examination (MMSE), respectively, at baseline and follow-ups, and converted into standardized scores. Linear mixed-effect model was used. Results show that elevated HDL-C was associated with increasing annual change rates in DWRT and MMSE scores (β (95% confidence intervals) = 0.005 (-0.001 to 0.011) SD/year and 0.020 (0.014 to 0.027) SD/year, respectively), while LDL-C and TC were associated with a decrease in DWRT scores (-0.005 (-0.008 to -0.001) SD/year and − 0.009 (-0.011 to -0.006) SD/year, respectively). Moderate-increasing HDL-C, high-decreasing LDL-C or moderate-decreasing TC trajectories were associated with increases in DWRT, IWRT and MMSE scores. Stronger associations were identified for HDL-C with an increase in MMSE scores within the lower family income group and for LDL-C with a decrease in IWRT scores among individuals taking lipid-lowering drug. In conclusion, HDL-C was associated with improvements, while LDL-C and TC with decline in memory and cognitive function. Increasing HDL-C and decreasing LDL-C and TC trajectories predicted better memory and cognitive performance. The observed effect modifications highlight the importance of personalized approaches in lipid management to optimize cognitive outcomes.
- Top Cited PapersOpen Access
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 5553491
Trends in Prevalent Cases and Disability‐Adjusted Life‐Years of Depressive Disorders Worldwide: Findings From the Global Burden of Disease Study From 1990 to 2021
Background: Depression is a primary public health challenge that affects individuals of all ages. This study aims to reveal information on spatial and temporal changes in depression by describing temporal trend differences, regional differences, and gender differences. Materials and Methods: Utilizing data from the Global Burden of Disease Study 2021 (GBD2021) from 1990 to 2021, we outlined the prevalence and burden of depression among 204 countries in 21 regions, including age and sex disparities, and explored the correlation between depressive burden and the sociodemographic index (SDI). The age‐standardized rates of prevalence (ASPR), disability‐adjusted life years (DALYs, age‐standardized DALY rate, ASDR), and estimated annual percentage change (EAPC) were employed to evaluate the global burden of depression. Results: Our study revealed a greater than 1.8‐fold increase in prevalent cases and DALYs for global depressive disorder from 1990 to 2021. Globally, the age‐standardized rates (ASRs) slightly declined, with a 1.32% decrease in the ASPR and a 1.84% decrease in the ASDR from 1990 to 2019. The main decline occurred from 2005 to 2010 (4.86% decrease in the ASPR and 6.09% decrease in the ASDR), with the majority of the contributions occurring in the low‐middle‐SDI and low‐SDI regions. The global ASPR and ASDR experienced astonishing jumps from 2019 to 2021, resulting in increases of nearly 11% in the ASPR and 13% in the ASDR. Notably, the ASPR and ASDR of depression decreased in females but increased in males from 1990 to 2019 and reversed thereafter. From 1990 to 2021, among the 21 regions, the EAPCs in most regions were >0, with the only exceptional decline occurring in East Asia in the ASPR −0.06 [95% Cl:−0.10 to −0.03]) and ASDR −0.09 [95% Cl:−0.13 to −0.05]). Compared with those in other regions, the ASPR (0.42 [95% Cl: 0.34–0.49]) and ASDR (0.53 [95% Cl: 0.46–0.61]) were greater in high‐income North America. Among the five SDI regions, the largest increases in ASPR (0.25 [95% Cl: 0.21–0.30]) and ASDR (0.31 [95% Cl: 0.26–0.37]) occurred in the high‐SDI region, with the majority of the contributions occurring from 2019 to 2021. Worldwide, a decreasing trend and significant associations between the ASPR and the SDI ( R = −0.22, p = 0.0013) and between the ASDR and the SDI ( R = −0.28, p < 0.001) were observed. Conclusion: Depression remains a serious challenge worldwide. The trends in depression burden varied across regions and groups. A vibrant socioeconomic environment could have a positive impact on the disease burden. Mental health should be incorporated into public health preparedness and emergency plans in practical ways on the basis of the national conditions of each country.
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 5553491
Top Cited PapersOpen AccessTrends in Prevalent Cases and Disability‐Adjusted Life‐Years of Depressive Disorders Worldwide: Findings From the Global Burden of Disease Study From 1990 to 2021
Background: Depression is a primary public health challenge that affects individuals of all ages. This study aims to reveal information on spatial and temporal changes in depression by describing temporal trend differences, regional differences, and gender differences. Materials and Methods: Utilizing data from the Global Burden of Disease Study 2021 (GBD2021) from 1990 to 2021, we outlined the prevalence and burden of depression among 204 countries in 21 regions, including age and sex disparities, and explored the correlation between depressive burden and the sociodemographic index (SDI). The age‐standardized rates of prevalence (ASPR), disability‐adjusted life years (DALYs, age‐standardized DALY rate, ASDR), and estimated annual percentage change (EAPC) were employed to evaluate the global burden of depression. Results: Our study revealed a greater than 1.8‐fold increase in prevalent cases and DALYs for global depressive disorder from 1990 to 2021. Globally, the age‐standardized rates (ASRs) slightly declined, with a 1.32% decrease in the ASPR and a 1.84% decrease in the ASDR from 1990 to 2019. The main decline occurred from 2005 to 2010 (4.86% decrease in the ASPR and 6.09% decrease in the ASDR), with the majority of the contributions occurring in the low‐middle‐SDI and low‐SDI regions. The global ASPR and ASDR experienced astonishing jumps from 2019 to 2021, resulting in increases of nearly 11% in the ASPR and 13% in the ASDR. Notably, the ASPR and ASDR of depression decreased in females but increased in males from 1990 to 2019 and reversed thereafter. From 1990 to 2021, among the 21 regions, the EAPCs in most regions were >0, with the only exceptional decline occurring in East Asia in the ASPR −0.06 [95% Cl:−0.10 to −0.03]) and ASDR −0.09 [95% Cl:−0.13 to −0.05]). Compared with those in other regions, the ASPR (0.42 [95% Cl: 0.34–0.49]) and ASDR (0.53 [95% Cl: 0.46–0.61]) were greater in high‐income North America. Among the five SDI regions, the largest increases in ASPR (0.25 [95% Cl: 0.21–0.30]) and ASDR (0.31 [95% Cl: 0.26–0.37]) occurred in the high‐SDI region, with the majority of the contributions occurring from 2019 to 2021. Worldwide, a decreasing trend and significant associations between the ASPR and the SDI ( R = −0.22, p = 0.0013) and between the ASDR and the SDI ( R = −0.28, p < 0.001) were observed. Conclusion: Depression remains a serious challenge worldwide. The trends in depression burden varied across regions and groups. A vibrant socioeconomic environment could have a positive impact on the disease burden. Mental health should be incorporated into public health preparedness and emergency plans in practical ways on the basis of the national conditions of each country.
- Open Access
- 30 October 2024
- Published by S. Karger AG in Cardiology
- Vol. 150 (4) , 1-12
Optimal QT Correction Formula for Older Chinese: Guangzhou Biobank Cohort Study
Introduction: To identify the optimal QT correction formula for generating corrected QT (QTc) and cutoffs for prolonged QTc, and examine the associations with mortality and cardiovascular disease (CVD) in older Chinese. Methods: A prospective study included 24,611 Chinese aged 50+ years and without CVD at 2003–2008 from Guangzhou Biobank Cohort Study. QT interval was corrected by Bazett, Fridericia, Framingham and Hodges formulas. The slope and R2 of the QTc and heart rate regression were used to determine the optimal correction formula. The 95th percentile of QTc was used to defined prolonged QTc. Cox regression was used to examine associations of prolonged QTc with mortality and CVD. The net reclassification index was calculated to assess risk reclassification. Results: During an average follow-up of 15.3 years, 5,261 deaths and 5,539 CVD occurred. Optimal heart correction was observed for the Hodges formula, and Bazett formula performed the worst. Prolonged QTc corrected by Fridericia, Framingham and Hodges formulas had similar association strength with all-cause mortality, CVD mortality and incident CVD (especially coronary heart disease, myocardial infarction and ischemic stroke), with hazard ratios approximately being 1.25, 1.40, and 1.15, respectively. They also improved risk reclassification for all-cause mortality, CVD mortality and incident CVD by approximately 5%, 10%, and 6%, respectively. However, prolonged QTc corrected by Bazett formula was not associated with incident CVD and did not improve risk reclassification. Conclusions: Hodges formula outperformed other formulas for heart rate correction. Fridericia, Framingham, and Hodges formulas can be used for death and cardiovascular risk prediction.
- 30 October 2024
- Published by S. Karger AG in Cardiology
- Vol. 150 (4) , 1-12
Open AccessOptimal QT Correction Formula for Older Chinese: Guangzhou Biobank Cohort Study
Introduction: To identify the optimal QT correction formula for generating corrected QT (QTc) and cutoffs for prolonged QTc, and examine the associations with mortality and cardiovascular disease (CVD) in older Chinese. Methods: A prospective study included 24,611 Chinese aged 50+ years and without CVD at 2003–2008 from Guangzhou Biobank Cohort Study. QT interval was corrected by Bazett, Fridericia, Framingham and Hodges formulas. The slope and R2 of the QTc and heart rate regression were used to determine the optimal correction formula. The 95th percentile of QTc was used to defined prolonged QTc. Cox regression was used to examine associations of prolonged QTc with mortality and CVD. The net reclassification index was calculated to assess risk reclassification. Results: During an average follow-up of 15.3 years, 5,261 deaths and 5,539 CVD occurred. Optimal heart correction was observed for the Hodges formula, and Bazett formula performed the worst. Prolonged QTc corrected by Fridericia, Framingham and Hodges formulas had similar association strength with all-cause mortality, CVD mortality and incident CVD (especially coronary heart disease, myocardial infarction and ischemic stroke), with hazard ratios approximately being 1.25, 1.40, and 1.15, respectively. They also improved risk reclassification for all-cause mortality, CVD mortality and incident CVD by approximately 5%, 10%, and 6%, respectively. However, prolonged QTc corrected by Bazett formula was not associated with incident CVD and did not improve risk reclassification. Conclusions: Hodges formula outperformed other formulas for heart rate correction. Fridericia, Framingham, and Hodges formulas can be used for death and cardiovascular risk prediction.
- Open Access
- 22 October 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-14
Global burden of ischemic stroke attributable to high body mass index in 204 countries and territories, 1990–2021
A high body mass index (hBMI) is one of the major risk factors for ischemic stroke (IS), although independent estimates of the global burden and trend of IS attributable to hBMI are unclear. Study data were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study and analysed by age, sex, year, and geographical location. The sociodemographic index (SDI) and the human development index (HDI) were used as indicators of national socioeconomic status. Geographic distributions and trends were assessed by calculating the estimated annual percentage change (EAPC). Associations between the age-standardized death rate (ASMR) or disability-adjusted life year rate (DALY) and socioeconomic status were analysed. Deaths and DALYs increased worldwide from 1990–2021, with increases of 95.74% for the former and 133.00% for the latter; the ASMR and ASDR decreased, with an ASMR and ASDR-related EAPCs of -1.10 (95% CI: -1.24–-0.96) and 0.04 (95% CI:-0.47–0.55), respectively; women had greater numbers of deaths and DALYs, and the majority of deaths and DALYs were shared by those aged ≥ 70. The highest burden rates were shared by Eastern Europe, North Africa, the Middle East, and Central Asia. The ASMR-related EAPCs were associated with the ASMR in 1990 (R = -0.35, P < 0.001) and the SDI in 2021 in different countries (R = -0.66, P < 0.001); these patterns were similar to those of the ASDR; the HDI in 2021 was associated with the ASMR-related EAPC (R = -0.71, P < 0.001) and the ASDR-related EAPC in different countries (R = -0.71, P < 0.001). The number of deaths and DALYs from ischemic stroke attributable to hBMI worldwide increased substantially from 1990–2021. Successful population-wide initiatives targeting hBMI may mitigate a wide range of burdens on this disease. Taking into account variations in the SDI burden, future prevention and control strategies must be developed and implemented according to country-specific development status.
- 22 October 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-14
Open AccessGlobal burden of ischemic stroke attributable to high body mass index in 204 countries and territories, 1990–2021
A high body mass index (hBMI) is one of the major risk factors for ischemic stroke (IS), although independent estimates of the global burden and trend of IS attributable to hBMI are unclear. Study data were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study and analysed by age, sex, year, and geographical location. The sociodemographic index (SDI) and the human development index (HDI) were used as indicators of national socioeconomic status. Geographic distributions and trends were assessed by calculating the estimated annual percentage change (EAPC). Associations between the age-standardized death rate (ASMR) or disability-adjusted life year rate (DALY) and socioeconomic status were analysed. Deaths and DALYs increased worldwide from 1990–2021, with increases of 95.74% for the former and 133.00% for the latter; the ASMR and ASDR decreased, with an ASMR and ASDR-related EAPCs of -1.10 (95% CI: -1.24–-0.96) and 0.04 (95% CI:-0.47–0.55), respectively; women had greater numbers of deaths and DALYs, and the majority of deaths and DALYs were shared by those aged ≥ 70. The highest burden rates were shared by Eastern Europe, North Africa, the Middle East, and Central Asia. The ASMR-related EAPCs were associated with the ASMR in 1990 (R = -0.35, P < 0.001) and the SDI in 2021 in different countries (R = -0.66, P < 0.001); these patterns were similar to those of the ASDR; the HDI in 2021 was associated with the ASMR-related EAPC (R = -0.71, P < 0.001) and the ASDR-related EAPC in different countries (R = -0.71, P < 0.001). The number of deaths and DALYs from ischemic stroke attributable to hBMI worldwide increased substantially from 1990–2021. Successful population-wide initiatives targeting hBMI may mitigate a wide range of burdens on this disease. Taking into account variations in the SDI burden, future prevention and control strategies must be developed and implemented according to country-specific development status.
- Open Access
- 27 August 2024
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 67 (1) , 1-44
Childhood socio-economic disadvantages versus adverse care experiences: Mediation and moderation impacts on late-life depressive symptoms
Background: Whether material deprivation-related childhood socio-economic disadvantages (CSD) and care-related adverse childhood experiences (ACE) have different impacts on depressive symptoms in middle-aged and older people is unclear. Methods: In the Guangzhou Biobank Cohort Study, CSD and ACE were assessed by 7 and 5 culturally sensitive questions, respectively, on 8,716 participants aged 50+. Depressive symptoms were measured by 15-item Geriatric Depression Scale (GDS). Multivariable linear regression, stratification analyses, and mediation analyses were done. Results: Higher CSD and ACE scores were associated with higher GDS score in dose-response manner (P for trend <0.001). Participants with one point increment in CSD and ACE had higher GDS score by 0.11 (95% confidence interval [CI], 0.09–0.14) and 0.41 (95% CI, 0.35–0.47), respectively. The association of CSD with GDS score was significant in women only (P for sex interaction <0.001; women: β (95% CI)=0.14 (0.11–0.17), men: 0.04 (−0.01 to 0.08)). The association between ACE and GDS score was stronger in participants with high social deprivation index (SDI) (P for interaction = 0.01; low SDI: β (95% CI)=0.36 (0.29–0.43), high SDI: 0.64 (0.48–0.80)). The proportion of association of CSD and ACE scores with GDS score mediated via education was 20.11% and 2.28%. Conclusions: CSD and ACE were associated with late-life depressive symptoms with dose-response patterns, especially in women and those with low adulthood socio-economic status. Education was a major mediator for CSD but not ACE. Eliminating ACE should be a top priority.
- 27 August 2024
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 67 (1) , 1-44
Open AccessChildhood socio-economic disadvantages versus adverse care experiences: Mediation and moderation impacts on late-life depressive symptoms
Background: Whether material deprivation-related childhood socio-economic disadvantages (CSD) and care-related adverse childhood experiences (ACE) have different impacts on depressive symptoms in middle-aged and older people is unclear. Methods: In the Guangzhou Biobank Cohort Study, CSD and ACE were assessed by 7 and 5 culturally sensitive questions, respectively, on 8,716 participants aged 50+. Depressive symptoms were measured by 15-item Geriatric Depression Scale (GDS). Multivariable linear regression, stratification analyses, and mediation analyses were done. Results: Higher CSD and ACE scores were associated with higher GDS score in dose-response manner (P for trend <0.001). Participants with one point increment in CSD and ACE had higher GDS score by 0.11 (95% confidence interval [CI], 0.09–0.14) and 0.41 (95% CI, 0.35–0.47), respectively. The association of CSD with GDS score was significant in women only (P for sex interaction <0.001; women: β (95% CI)=0.14 (0.11–0.17), men: 0.04 (−0.01 to 0.08)). The association between ACE and GDS score was stronger in participants with high social deprivation index (SDI) (P for interaction = 0.01; low SDI: β (95% CI)=0.36 (0.29–0.43), high SDI: 0.64 (0.48–0.80)). The proportion of association of CSD and ACE scores with GDS score mediated via education was 20.11% and 2.28%. Conclusions: CSD and ACE were associated with late-life depressive symptoms with dose-response patterns, especially in women and those with low adulthood socio-economic status. Education was a major mediator for CSD but not ACE. Eliminating ACE should be a top priority.